skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Download Informa Pharma Intelligence's Pulse Report

This year, the vaccine development process has been shoved into the spotlight as groups across the globe race to get approval for a COVID-19 vaccine. A new focus on exactly what goes into vaccine development has prompted intense scrutiny from the American public on the clinical trial process. While many were ware of clinical trials before the COVID-19 pandemic, the virus has caused most Americans to pay closer attention over the past few months. Yet, this focus hasn’t resulted in increased confidence as more than
half of Americans have said they’re not comfortable taking a COVID-19 vaccine upon approval.

The goal of our Clinical Trials & the COVID-19 Vaccine Pulse Report was to examine why this may be the case, and how industry players could increase confidence.
COVID-19 Pulse report